Judged by histology quantitation, IHC analysis and immunoprofiling data, NF-κB inhibition compromised Arid1a-deleted tumor progression along with the reduced PMN-MDSC infiltrations and expansion of CD8+ T cells (Fig. 7f and Supplementary Fig. 7e, f). This evidence concerns the gene NFKB1 and neoplasm.